
Assoziierte(r) Prof. Dr. Jens Hartmann
Fachbereichsleiter Medizinische Verfahrenstechnik - Zentrum für Biomedizinische Technologie
- jens.hartmann@donau-uni.ac.at
- +43 2732 893-2623
- Zum Kontaktformular
- Campus Krems, Trakt C, 3. Stock, 3.11
- Universität für Weiterbildung Krems
- Zentrum für Biomedizinische Technologie
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Publikationen (Auszug Forschungsdatenbank)
Pilecky, M.; Harm, S.; Bauer, C.; Zottl, J.; Emprechtinger, R.; Eichhorn, T.; Schildböck, C.; Ecker, M.; Willheim, M.; Weber, V.; Hartmann, J. (2022). Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR. J Infect, Jan 14: S0163-4453(22)00011-1
Harm, S.; Schildböck, C.; Strobl, K.; Hartmann, J. (2021). An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test. Sci Rep, 11(1): 4192
Strobl, K.; Harm, S.; Fichtinger, U.; Schildböck, C.; Hartmann, J. (2021). Impact of anion exchange adsorbents on regional citrate anticoagulation. Int J Artif Organs, 44(3): 149-155
Harm, S.; Schildböck, C.; Hartmann, J. (2020). Cytokine removal in extracorporeal blood purification: An in vitro study. Blood Purif, 49(1-2): 33-43
Kielbassa, A.M.; Leimer, M.R.; Hartmann, J.; Harm, S.; Pasztorek, M.; Ulrich, I.B. (2020). Ex vivo investigation on internal tunnel approach/internal resin infiltration and external nanosilver-modified resin infiltration of proximal caries exceeding into dentin. PLoS ONE, 15(1): e0228249
Harm, S.; Lohner, K.; Fichtinger, U.; Schildböck, C.; Zottl, J.; Hartmann, J. (2019). Blood compatibility - an important but often forgotten aspect of the characterization of antimicrobial peptides for clinical application. Int J Mol Sci, 20(21): 5426
Gubensek, J.; Strobl, K.; Harm, S.; Weiss, R.; Eichhorn, T.; Buturovic-Ponikvar, J.; Weber, V.; Hartmann, J. (2018). Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup. PLoS ONE, 13(6):e0199204: doi: 10.1371/journal.pone.0199204
Harm, S.; Schildböck, C.; Hartmann, J. (2018). Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS One, Jan 24;13(1): 10.1371/journal.pone.0191741
Eichhorn, T.; Hartmann, J.; Harm, S.; Linsberger, I.; König, F.; Valicek, G.; Miestinger, G.; Hörmann, C.; Weber, V. (2017). Clearance of selected cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purification, 44(4): 260-266
Hartmann, J.; Harm, S. (2017). Removal of bile acids by extracorporeal therapies: an in vitro study. International Journal of Artificial Organs, doi: 10.5301/ijao.5000643: doi: 10.5301/ijao.5000643
Hartmann, J.; Harm, S. (2017). A new integrated technique for the supportive treatment of sepsis. International Journal of Artificial Organs, 40(1): 4-8
Strobl, K.; Harm, S.; Weber, V.; Hartmann, J. (2017). The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. International Journal of Artificial Organs, 40(1): 15-21
Harm, S.; Hartmann, J. (2017). Removal of stabilizers from human serum albumin by nanostructured adsorbents. BioNanoMed Congress, March 2017, Krems, Austria
Hartmann, J.; Harm, S. (2017). Cytokine induction in human blood by fractionated bacterial lysates. BioNanoMed Congress, March 2017, Krems, Austria
Harm, S.; Gabor, F.; Hartmann, J. (2016). Low-Dose Polymyxin: an Option for Therapy of Gram-Negative Sepsis. Innate Immunity, 2016: 274-283
Harm, S.; Gruber, A.; Gabor, F.; Hartmann, J. (2016). Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification. Blood Purification, 2016(41): 55-63
Harm, S.; Hartmann, J. (2016). Polymyxin-Coated Nanostructured Materials: An Option for Sepsis Treatment. Journal of Nanomaterials & Molecular Nanotechnology, 10.4172/2324-8777.S4-003
Harm, S.; Hartmann, J. (2016). Low-Dose Polymyxin: An Option for Therapy of Gram-Negative Sepsis. Innate Immunity, March 2016. DOI: 10.1177/17534259
Harm, S.; Gabor, F.; Hartmann, J. (2015). In vitro characterization of a new adsorbent for cytokines in extracorporeal blood purification. Shock, 44 Suppl 2:9
Harm, S.; Gabor, F.; Hartmann, J. (2015). Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model. Journal of Immunology Research, Vol. 2015, Article ID 484736
Patente (Auszug Forschungsdatenbank)
Dosieranleitung für endotoxinbindende Lipopeptide
Dosing instructions for endotoxin-binding lipopeptides [Translation]
Zentrum für Biomedizinische Technologie
Patent-Nr: WO2014001444A1, Status: Erteilung
Assoziierte(r) Prof. Dr. Jens Hartmann, Dipl.-Ing. Dr. Stephan Harm
Verfahren zum Erfassen der Ionenkonzentration bei citrat-antikoagulierter extrakorporaler Blutreinigung
Method for measuring the ion concentration in citrate-anticoagulated extracorporeal blood purification [Translation]
Zentrum für Biomedizinische Technologie
Patent-Nr: AT505690B1, Status: Lizenz
Assoziierte(r) Prof. Dr. Jens Hartmann, Dipl.-Ing. Dr. Martin Brandl, Mag. Karin Strobl, MSc